Hsa-miR-100-5p promotes the development and progression of gastric cancer through targeted atypical chemokine receptor 3. [PDF]
Wang XL +8 more
europepmc +1 more source
Bystander Expression of Atypical Chemokine Receptor 2 Protects T Cells from Chemoattraction towards Cancer-Associated Fibroblasts. [PDF]
Tang R +7 more
europepmc +1 more source
Deletion of atypical chemokine receptor 3 (ACKR3) increases immune cells at the fetal-maternal interface. [PDF]
Quinn KE, Matson BC, Caron KM.
europepmc +1 more source
Targeting the atypical chemokine receptor 2 (<i>Ackr2</i>) improves the benefit of anti-PD-1 immunotherapy in melanoma mouse model. [PDF]
Noman MZ +9 more
europepmc +1 more source
Biphasic Expression of Atypical Chemokine Receptor (ACKR) 2 and ACKR4 in Colorectal Neoplasms in Association with Histopathological Findings. [PDF]
Lewandowska P +4 more
europepmc +1 more source
Atypical Chemokine Receptor 1 (Ackr1) -deficient Mice Resist Lethal SARS-CoV-2 Challenge
Majumdar S +14 more
europepmc +1 more source
Heterogeneous expression of the atypical chemokine receptor ACKR3 in glioblastoma patient-derived tissue samples and cell cultures. [PDF]
Isci D +9 more
europepmc +1 more source
Small Molecule Fluorescent Ligands for the Atypical Chemokine Receptor 3 (ACKR3). [PDF]
Dekkers S +12 more
europepmc +1 more source
Novel neutrophil biology insights underlying atypical chemokine receptor-1/Duffy antigen receptor of chemokines-associated neutropenia. [PDF]
Liu JM, Luo HR.
europepmc +1 more source
Atypical chemokine receptor ACKR2-V41A has decreased CCL2 binding, scavenging, and activation, supporting sustained inflammation and increased Alzheimer's disease risk. [PDF]
Murcia JDG +9 more
europepmc +1 more source

